These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19465902)

  • 1. Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
    Tretiakova MS; Hart J; Shabani-Rad MT; Zhang J; Gao ZH
    Mod Pathol; 2009 Aug; 22(8):1113-20. PubMed ID: 19465902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma.
    Gao ZH; Tretiakova MS; Liu WH; Gong C; Farris PD; Hart J
    Mod Pathol; 2006 Apr; 19(4):533-40. PubMed ID: 16474379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.
    Lagana SM; Salomao M; Bao F; Moreira RK; Lefkowitch JH; Remotti HE
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):170-6. PubMed ID: 22914605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum.
    Shafizadeh N; Ferrell LD; Kakar S
    Mod Pathol; 2008 Aug; 21(8):1011-8. PubMed ID: 18536657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
    Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
    Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.
    van Dekken H; Verhoef C; Wink J; van Marion R; Vissers KJ; Hop WC; de Man RA; IJzermans JN; van Eijck CH; Zondervan PE
    Acta Histochem; 2005; 107(3):161-71. PubMed ID: 16000213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of matrix metalloproteinases in colorectal carcinogenesis.
    Heslin MJ; Yan J; Johnson MR; Weiss H; Diasio RB; Urist MM
    Ann Surg; 2001 Jun; 233(6):786-92. PubMed ID: 11371737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion.
    Cokakli M; Erdal E; Nart D; Yilmaz F; Sagol O; Kilic M; Karademir S; Atabey N
    BMC Cancer; 2009 Feb; 9():65. PubMed ID: 19239691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of MDM2 and MMP-7 in normal liver, cirrhosis, hepatocellular carcinoma tissues].
    Kang KF; Zhang X; Chen XW
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):67-8. PubMed ID: 20128976
    [No Abstract]   [Full Text] [Related]  

  • 11. Anterior gradient-2 is overexpressed by fibrolamellar carcinomas.
    Vivekanandan P; Micchelli ST; Torbenson M
    Hum Pathol; 2009 Mar; 40(3):293-9. PubMed ID: 18973922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome-localized hepatitis Bx protein increases the invasion property of hepatocellular carcinoma cells.
    Han JM; Kang JA; Han MH; Chung KH; Lee CR; Song WK; Jun Y; Park SG
    Arch Virol; 2014 Oct; 159(10):2549-57. PubMed ID: 24810099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver.
    Kozyraki R; Scoazec JY; Flejou JF; D'Errico A; Bedossa P; Terris B; Fiorentino M; Bringuier AF; Grigioni WF; Feldmann G
    Gastroenterology; 1996 Apr; 110(4):1137-49. PubMed ID: 8613003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.
    Kakar S; Grenert JP; Paradis V; Pote N; Jakate S; Ferrell LD
    Mod Pathol; 2014 Nov; 27(11):1499-1509. PubMed ID: 24743216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y; Koda M; Murawaki Y
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Highly differentiated liver tumors: recent developments and their diagnostic application].
    Schirmacher P; Longerich T
    Pathologe; 2009 Dec; 30 Suppl 2():200-6. PubMed ID: 19908045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma.
    Nguyen TB; Roncalli M; Di Tommaso L; Kakar S
    Mod Pathol; 2016 Mar; 29(3):283-92. PubMed ID: 26769138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microRNA-200 family--a potential diagnostic marker in hepatocellular carcinoma?
    Dhayat SA; Mardin WA; Köhler G; Bahde R; Vowinkel T; Wolters H; Senninger N; Haier J; Mees ST
    J Surg Oncol; 2014 Sep; 110(4):430-8. PubMed ID: 24895326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition.
    Zhou Y; Li Y; Ye J; Jiang R; Yan H; Yang X; Liu Q; Zhang J
    Liver Int; 2013 Sep; 33(8):1271-80. PubMed ID: 23725476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.